v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2024   162,018      
Beginning balance at Dec. 31, 2024 $ 964,799 $ 16 $ 1,173,153 $ 426 $ (208,796)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and vesting of early exercised stock options (in shares)   2,334      
Issuance of common stock upon exercise of stock options and vesting of early exercised stock options 2,088   2,088    
Issuance of common stock upon vesting of restricted stock units (in shares)   4,492      
Issuance of common stock upon vesting of restricted stock units 1 $ 1      
Shares issued under employee stock purchase plan (in shares)   59      
Shares issued under employee stock purchase plan 4,345   4,345    
Stock-based compensation 118,659   118,659    
Warrants contra revenue 4,016   4,016    
Unrealized (loss) gains on marketable securities 3,671     3,671  
Net income 174,152       174,152
Ending balance (in shares) at Sep. 30, 2025   168,903      
Ending balance at Sep. 30, 2025 1,271,731 $ 17 1,302,261 4,097 (34,644)
Beginning balance (in shares) at Jun. 30, 2025   166,211      
Beginning balance at Jun. 30, 2025 1,135,714 $ 17 1,258,581 2,874 (125,758)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and vesting of early exercised stock options (in shares)   1,438      
Issuance of common stock upon exercise of stock options and vesting of early exercised stock options 1,060   1,060    
Issuance of common stock upon vesting of restricted stock units (in shares)   1,254      
Issuance of common stock upon vesting of restricted stock units 0        
Stock-based compensation 40,739   40,739    
Warrants contra revenue 1,881   1,881    
Unrealized (loss) gains on marketable securities 1,223     1,223  
Net income 91,114       91,114
Ending balance (in shares) at Sep. 30, 2025   168,903      
Ending balance at Sep. 30, 2025 $ 1,271,731 $ 17 1,302,261 4,097 (34,644)
Beginning balance (in shares) at Dec. 31, 2025 170,186 170,186      
Beginning balance at Dec. 31, 2025 $ 1,363,634 $ 17 1,348,969 4,310 10,338
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and vesting of early exercised stock options (in shares) 1,031 1,031      
Issuance of common stock upon exercise of stock options and vesting of early exercised stock options $ 834   834    
Issuance of common stock upon vesting of restricted and performance stock units (in shares)   3,357      
Issuance of common stock upon vesting of restricted and performance stock units 0        
Issuance of common stock upon exercise of warrants (in shares)   126      
Issuance of common stock upon exercise of warrants 0        
Shares issued under employee stock purchase plan (in shares)   52      
Shares issued under employee stock purchase plan 6,294   6,294    
Stock-based compensation 199,465   199,465    
Warrants contra revenue 30,397   30,397    
Unrealized (loss) gains on marketable securities (17,498)     (17,498)  
Net income $ 416,342       416,342
Ending balance (in shares) at Sep. 30, 2026 174,752 174,752      
Ending balance at Sep. 30, 2026 $ 1,999,468 $ 17 1,585,959 (13,188) 426,680
Beginning balance (in shares) at Jun. 30, 2026   173,485      
Beginning balance at Jun. 30, 2026 1,725,704 $ 17 1,485,320 (3,369) 243,736
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and vesting of early exercised stock options (in shares)   3      
Issuance of common stock upon exercise of stock options (35)   (35)    
Issuance of common stock upon vesting of restricted and performance stock units (in shares)   1,264      
Issuance of common stock upon vesting of restricted and performance stock units 0        
Stock-based compensation 82,590   82,590    
Warrants contra revenue 18,084   18,084    
Unrealized (loss) gains on marketable securities (9,819)     (9,819)  
Net income $ 182,944       182,944
Ending balance (in shares) at Sep. 30, 2026 174,752 174,752      
Ending balance at Sep. 30, 2026 $ 1,999,468 $ 17 $ 1,585,959 $ (13,188) $ 426,680